These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6146154)

  • 1. Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression.
    Vaccheri A; Dall'Olio R; Gaggi R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1984; 83(1):28-33. PubMed ID: 6146154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic versus antidepressant activity of sulpiride isomers in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Adv Biochem Psychopharmacol; 1982; 31():341-6. PubMed ID: 6123224
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism by sulpiride of three apomorphine-induced effects in rodents.
    Puech AJ; Simon P; Boissier JR
    Eur J Pharmacol; 1976 Apr; 36(2):439-41. PubMed ID: 945169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the apomorphine-induced yawning by "atypical" neuroleptics.
    Dubuc I; Protais P; Colboc O; Costentin J
    Neuropharmacology; 1982 Nov; 21(11):1203-6. PubMed ID: 6129594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.
    Puech AJ; Chermat R; Poncelet M; Doaré L; Simon P
    Psychopharmacology (Berl); 1981; 75(1):84-91. PubMed ID: 6117921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nucleus accumbens and antidepressants: modulation of ergometrine-induced hyperactivity by typical and atypical antidepressants and neuroleptics in rats.
    Cools AR
    Psychopharmacology (Berl); 1987; 92(3):350-7. PubMed ID: 2888148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piracetam interactions with neuroleptics in psychopharmacological tests.
    Bourin M; Poisson L; Larousse C
    Neuropsychobiology; 1986; 16(2-3):93-6. PubMed ID: 2884593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of repeated treatment with desipramine in the behavioral "despair" test in rats: antagonism by "atypical" but not "classical" neuroleptics or antiadrenergic drugs.
    Borsini F; Nowakowska E; Samanin R
    Life Sci; 1984 Mar; 34(12):1171-6. PubMed ID: 6143232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural 'despair' test in rats.
    Borsini F; Pulvirenti L; Samanin R
    Eur J Pharmacol; 1985 Apr; 110(2):253-6. PubMed ID: 3987815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The drug-induced helplessness test: an animal assay for assessing behavioral despair in response to neuroleptic treatment.
    Ballard ME; Basso AM; Gallagher KB; Browman KE; Fox GB; Drescher KU; Gross G; Decker MW; Rueter LE; Zhang M
    Psychopharmacology (Berl); 2007 Jan; 190(1):1-11. PubMed ID: 17093979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dopamine D-1 and D-2 antagonists on decision making by rats: no reversal of neuroleptic-induced attenuation by scopolamine.
    Ljungberg T; Enquist M
    J Neural Transm Gen Sect; 1990; 82(3):167-79. PubMed ID: 1979001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paw test: a behavioural paradigm for differentiating between classical and atypical neuroleptic drugs.
    Ellenbroek BA; Peeters BW; Honig WM; Cools AR
    Psychopharmacology (Berl); 1987; 93(3):343-8. PubMed ID: 2893411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.
    Dall'Olio R; Gandolfi O; Roncada P; Vaccheri A; Montanaro N
    Psychopharmacology (Berl); 1990; 100(4):560-2. PubMed ID: 1969667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.
    Ståhle L; Ungerstedt U
    Pharmacol Biochem Behav; 1986 Aug; 25(2):473-80. PubMed ID: 2876441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of (-)-sulpiride and YM-09151-2 on stereotyped behavior in chicks and catalepsy in rats.
    Wambebe C
    Jpn J Pharmacol; 1987 Feb; 43(2):121-8. PubMed ID: 2883335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior.
    Vergoni AV; Forgione A; Bertolini A
    Psychopharmacology (Berl); 1995 Sep; 121(2):279-81. PubMed ID: 8545534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.